Corcept Therapeutics
CORT
#3163
Rank
C$6.75 B
Marketcap
C$62.95
Share price
2.17%
Change (1 day)
-36.78%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2025 (TTM): C$61.58 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are C$0.76 Billion. a decrease over its 2024 earnings that were of C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 C$61.22 M-67.29%
2024 C$0.18 B27.66%
2023 C$0.14 B-4.75%
2022 C$0.15 B-9.51%
2021 C$0.17 B-2.91%
2020 C$0.17 B14.87%
2019 C$0.15 B24.71%
2018 C$0.12 B69.32%
2017 C$72.24 M419.26%
2016 C$13.91 M-395.64%
2015 -C$4.71 Million-87.53%
2014 -C$37.76 Million-33.44%
2013 -C$56.72 Million
2011 -C$44.2 Million17.84%
2010 -C$37.51 Million35.5%
2009 -C$27.68 Million2.84%
2008 -C$26.92 Million60.81%
2007 -C$16.74 Million-52.14%
2006 -C$34.97 Million20.91%
2005 -C$28.93 Million31.87%
2004 -C$21.94 Million60.54%
2003 -C$13.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$45.85 B 74,797.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.34 B 36,402.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$13.93 B 22,651.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$35.16 B 57,339.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$30.64 B 49,954.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.74 B 20,722.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$42.07 M-31.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-C$37.51 Million-161.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.65 B 977.04%๐Ÿ‡บ๐Ÿ‡ธ USA